CD274 and neoplasm: Binding of the programmed death receptor‐1 (PD‐1) to its ligand, programmed death protein ligand‐1 (PD‐L1), triggers inhibitory signals that result in reduced proliferation of many anti-tumor immune cells, thereby preventing effector immune cells from killing cancer cells.